BridgeMD
New treatment option for Diabetic Polyneuropathy
Official title Driving with Neuropathy
ClinicalTrials.gov ID: NCT06739135
What this study is testing
- What it's testing
- This study is a proof-of-concept randomised controlled trial (RCT). The goal of the study is to investigate the effectiveness of a feedback intervention to improve use of the accelerator pedal in patients driving with diabetes and peripheral neuropathy (DPN).
- Time commitment: about 5 years
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 69
You may be able to join if
- Able to understand English and all of the study requirements, including ability to provide informed consent
- Current full UK driving licence held, and for a minimum of 5 years (experienced drivers)
- Drives a car at least once per week on average (current drivers)
- Diagnosed with type 2 diabetes and diabetic peripheral neuropathy
- Diagnosed with type 2 diabetes only (no diagnosed diabetic peripheral neuropathy)
You likely can't join if
- Active foot ulcer on either foot
- Lower limb amputation involving more than two toes on the right foot
- Dementia
- Current participation in another research study that would compromise safety, or scientific integrity of either study (for example, a pharmaceutical...
The study team makes the final eligibility decision.
Where it's taking place
- Manchester, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 5 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 69 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Manchester, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.